Clinical trial
A 4-week Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain
NCT00387010 is registered in ClinicalTrials.gov with Cephalon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 4-week Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Pain
- Lead sponsor
- Cephalon
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 31, 2006
- Completion date
- October 31, 2007
- Enrollment
- 218 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.